Linear Polyol Stabilized Polyfluoroacrylate for Hyperkalemia
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current potassium-binding polymers used to treat hyperkalemia, such as polystyrene sulfonate cation exchange polymers, face patient compliance issues due to dosing frequency, taste, texture, and gastrointestinal side effects, leading to reduced efficacy and increased adverse reactions.
Innovation Solution
A pharmaceutical composition comprising a salt of a crosslinked cation exchange polymer stabilized with a linear polyol, which is administered once or twice daily, reducing fluoride release and minimizing gastrointestinal side effects while maintaining potassium binding efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If crosslinked cation exchange polymer is used to treat hyperkalemia, then potassium binding efficacy is improved, but gastrointestinal side effects and patient compliance deteriorate
Solution Approach 1:
A linear polyol stabilizer is introduced as an intermediary substance between the crosslinked cation exchange polymer and the gastrointestinal tract. The polyol stabilizer reduces fluoride ion release from the polymer, thereby minimizing gastrointestinal irritation and side effects while allowing the polymer to maintain its potassium binding function. This mediator approach resolves the contradiction by protecting the patient from harmful effects without compromising therapeutic efficacy.
Solution Approach 2:
The invention changes the chemical composition parameters of the polymer formulation by incorporating a linear polyol stabilizer at specific concentrations (0.1-10 wt%). This parameter change stabilizes the polymer structure, reduces fluoride release, and improves patient tolerance. The stabilized polymer can then be administered at lower doses with reduced frequency, improving compliance while maintaining efficacy.
2Reliability
If multiple daily doses are administered to maintain potassium binding efficacy, then therapeutic effectiveness is improved, but patient compliance and dosing convenience deteriorate
Solution Approach 1:
The linear polyol stabilizer is incorporated into the polymer formulation in advance, creating a stabilized polymer product before administration. This preliminary stabilization allows the polymer to maintain its efficacy over extended periods, enabling less frequent dosing schedules (once or twice daily instead of multiple times daily) while maintaining therapeutic effectiveness. The stabilizer pre-prepares the polymer for sustained performance.
Solution Approach 2:
The linear polyol stabilizer enables continuous stable performance of the polymer over extended time periods. By preventing polymer degradation and fluoride release, the stabilizer allows the polymer to maintain its potassium binding capacity throughout the dosing interval, making once or twice daily dosing effective rather than requiring multiple daily administrations.
3Object-affected harmful factors
If sorbitol is co-administered to prevent constipation, then gastrointestinal tolerance is improved, but diarrhea and other side effects worsen
Solution Approach 1:
The linear polyol stabilizer serves as an intermediary that prevents constipation through its lubricating effect on the gastrointestinal tract, similar to sorbitol, but without causing the harmful side effects. The stabilizer is chemically incorporated into the polymer formulation, creating a unified composition that provides both constipation prevention and avoids the diarrhea-inducing effects of sorbitol co-administration.
4Stability of the object's composition
If polymer composition is stabilized with linear polyol, then storage stability and fluoride release reduction are improved, but formulation complexity increases
Solution Approach 1:
The invention modifies the formulation parameters by incorporating a linear polyol stabilizer at optimized concentrations (0.1-10 wt%). This parameter change provides significant storage stability improvement and fluoride release reduction. The complexity increase is minimal since the polyol is simply mixed with the polymer powder, and the benefit-to-complexity ratio is favorable given the substantial improvement in stability and reduced fluoride release.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition achieves similar potassium binding efficacy to multiple daily doses with reduced gastrointestinal adverse events, enhancing patient compliance and stability during storage.
Implementation Method 1
linear polyols in particular have a stabilizing effect during storage on crosslinked poly alpha-fluoroacrylic acid in its salt form
Implementation Method 2
These polymers and polymer compositions are known to have patient compliance issues... Various medical conditions... can lead to or predispose patients to hyperkalemia. Hyperkalemia can be treated with various cation exchange polymers including polyfluoroacrylic acid
Data Source
AI summary
The present invention is directed to compositions of a linear polyol and a salt of a crosslinked cation exchange polymer comprising a fluoro group and an acid group. These compositions are useful to bind potassium in the gastrointestinal tract.